Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on November 2, 2009

Hypertension. 2009
Published online before print November 2, 2009, doi: 10.1161/HYPERTENSIONAHA.109.140715
A more recent version of this article appeared on December 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
54/6/1369    most recent
HYPERTENSIONAHA.109.140715v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nakamura, T.
Right arrow Articles by Sapru, H. N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, T.
Right arrow Articles by Sapru, H. N.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Autonomic, reflex, and neurohumoral control of circulation

Submitted on August 6, 2009
Revised on August 27, 2009

Cardiovascular Responses to Hypothalamic Arcuate Nucleus Stimulation in the Rat. Role of Sympathetic and Vagal Efferents

Takeshi Nakamura; Suresh Bhatt; and Hreday N. Sapru*

From the Department of Neurological Surgery, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, N.J.

* To whom correspondence should be addressed. E-mail: sapru{at}umdnj.edu.

Abstract—Experiments were carried out in urethane-anesthetized, artificially ventilated, adult male Wistar rats. Microinjections (50 nL) of N-methyl-D-aspartic acid (1, 5, and 10 mmol/L), but not artificial cerebrospinal fluid, into the hypothalamic arcuate nucleus (ARCN) elicited increases in mean arterial pressure (5.7±0.5, 13.2±1.4, and 17.3±1.1 mm Hg, respectively) and heart rate (24.3±4.3, 49.3±5.2, and 75.2±8.0 bpm, respectively). ARCN stimulation was accomplished by microinjections of a maximally effective concentration of N-methyl-D-aspartic acid (10 mmol/L). The tachycardic responses to the ARCN stimulation were significantly attenuated after bilateral vagotomy. Intrathecal injections of ionotropic glutamate receptor (iGLUR) antagonists completely blocked pressor responses to the ARCN stimulation, whereas the tachycardic responses were significantly attenuated but not abolished. Intrathecal injections of iGLUR antagonists at T9 to T10, combined with bilateral vagotomy, completely blocked the tachycardic responses to ARCN stimulation. ARCN stimulation with N-methyl-D-aspartic acid elicited increased activities of the greater splanchnic nerve (91.7±14.8%) and the renal nerve (109.3±13%). Intrathecal injections of iGLURs at T9 to T10 blocked the increase in the greater splanchnic nerve activity in response to ARCN stimulation. These results indicate the following: (1) the chemical stimulation of the ARCN elicits increases in mean arterial pressure, greater splanchnic nerve and renal nerve activity, and heart rate; (2) the increases in mean arterial pressure and sympathetic nerve activity are mediated via the activation of spinal cord iGLURs; and (3) the increases in heart rate are mediated via the activation of spinal cord iGLURs and decreases in vagal input to the heart.


Key words: blood pressure • heart rate • intrathecal injection • microinjection • N-methyl-D-aspartic acid • sympathetic nerve activity